Ocular Therapeutix, Inc.

NASDAQ:OCUL

Biotechnology

Healthcare
$5.86 -1.17%

-$0.11 today

Market cap
$1.29B
Beta
0.90
P/E (TTM)
-7.3
EPS (TTM)
-$1.30
52W Low $6.23High $16.44

Volume 3.08M

Average 3.00M

Balance Sheet

Inspect the capital base behind the business.

Assets

$808.06M

FY 2025 · Annual

+76.5% YoY

Liabilities

$153.75M

FY 2025 · Annual

+7.8% YoY

Equity

$654.31M

FY 2025 · Annual

+107.5% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents164.16M102.3M195.81M392.1M737.06M
Short-term Investments00000
Net Receivables21.14M21.33M26.18M32.39M30.65M
Inventory1.25M1.97M2.31M3.04M3.56M
Other Current Assets04.03M7.94M13.46M10.86M
Total Current Assets191.3M129.63M232.24M440.99M782.13M
Property, Plant & Equipment (Net)11.82M17.9M18.21M15.33M24.31M
Goodwill00000
Intangible Assets00000
Long-term Investments00001.61M
Tax Assets00000
Other Non-current Assets1.76M1.76M1.61M1.61M0
Total Non-current Assets13.59M19.66M19.83M16.95M25.93M
Total Assets204.89M149.29M252.06M457.94M808.06M
Account Payables4.59M5.12M4.39M4.18M4.15M
Short-term Debt00002.82M
Tax Payables00000
Deferred Revenue0576K255K128K0
Other Current Liabilities000025.86M
Total Current Liabilities26.34M31.4M34.9M41.35M50.81M
Long-term Debt51.44M54.01M74.93M68.51M74.15M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)13M13.39M14.14M14M14M
Other Non-current Liabilities20.19M6.44M30.1M13.39M11.98M
Total Non-current Liabilities90.55M82.52M126.03M101.24M102.94M
Total Liabilities116.89M113.91M160.93M142.59M153.75M
Common Stock8K8K12K16K22K
Retained Earnings(545.8M)(616.84M)(697.58M)(891.08M)(1.16B)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity88M35.38M91.13M315.34M654.31M
Total Debt58.98M64.28M83.39M75.78M79.78M
Net Debt(105.18M)(38.02M)(112.42M)(316.32M)(657.28M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$666.7M
Receivables$24.3M
Inventory$3.7M
Other Current$11.2M
Total Current Assets$706.0M
PP&E (Net)$24.9M
Long-term Investments$1.6M
Other Non-current-$1
Total Non-current Assets$26.5M
Total Assets$732.5M

Analysis

Selected assets total $732.5M for Latest. The largest visible component is Cash & Equivalents at $666.7M, about 91.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 10, 2026
3Initial statement of beneficial ownershipNov 10, 2026
8-KCurrent reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
10-QQuarterly reportNov 9, 2026

How much cash does OCUL have?

Ocular Therapeutix, Inc. (OCUL) reported $737.06M in cash and equivalents in fiscal 2025.

How much debt does OCUL carry?

Ocular Therapeutix, Inc. (OCUL) reported $79.78M of total debt, with net debt of -$657.28M.